Position in BCRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,600
+$1,039 QoQ
Shares Held
160
+171.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#295
of 316 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $1,662,942 across 40 Drug Manufacturers - Specialty & Generic names. BCRX ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,233 | $1,022,783 | |
| 2 | HLN |
Haleon plc
|
20,447 | $190,770 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,765 | $93,678 | |
| 4 | VTRS |
Viatris Inc
|
4,374 | $69,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
345 | $58,146 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,008 | $49,416 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
3,338 | $48,367 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,343 | $46,561 |
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,600 | 160 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $561 | 59 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $31 | 4 | Shares | Sole | 2026-02-09 | |
| 2025-06-30 | $152 | 17 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||